VVPR - ABBV and ACER among premarket losers June, 25 2019 09:17 AM VivoPower International PLC Acer Therapeutics (NASDAQ:ACER) -79% after FDA rejects Edsivo application for rare connective tissue disorder.More news on: Acer Therapeutics Inc., Cemtrex, Inc., Aldeyra Therapeutics, Inc., Stocks on the move, Read more ...